Arber DA, Orazi A, Hasserjian RP, Brunning RD, Le Beau MM, Porwit A, Tefferi A, Levine R, Bloomfield CD, Cazzola M, Thiele J (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC press, Lyon
Glockenberg K, Weinberg EM, Wan DW (2015) A sinister cause of hematemesis. Gastroenterology. https://doi.org/10.1053/j.gastro.2014.09.033
Valla D, Casadevall N, Huisse MG, Tulliez M, Grange JD, Muller O, Binda T, Varet B, Rueff B, Benhamou JP (1988) Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastrenterology 94:1063–1069
Smalberg JH, Darwish MS, Braakman E, Valk PJ, Janssen HL, Leebeek FW (2006) Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome. Haematologica 91:1712–1713
Kiladjian JJ, Cervantes F, Leebeek FW, Marzac C, Cassinat B, Chevret S, Cazals-Hatem D, Plessier A, Garcia-Pagan JC, Darwish Murad S, Raffa S, Janssen HL, Gardin C, Cereja S, Tonetti C, Giraudier S, Condat B, Casadevall N, Fenaux P, Valla DC (2008) The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood 111:4922–4929
Article CAS PubMed Google Scholar
Turon F, Cervantes F, Colomer D, Baiges A, Hernandez-Gea V, Garcia-Pagan JC (2015) Role of calreticulin mutations in aetiological diagnosis of splanchnic vein thrombosis. J Hepatol 62:72–74
Article CAS PubMed Google Scholar
Smalberg JH, Arends LR, Valla DC, Kiladjian JJ, Janssen HL, Leebeek FW (2012) Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood 120:4921–4928
Article CAS PubMed Google Scholar
Degott C, Capron JP, Bettan L, Molas G, Bernuau D, Potet F, Feldmann G, Benhamou JP (1985) Myeloid metaplasia, perisinusoidal fibrosis and nodular regenerative hyperplasia of the liver. Liver 5:276–281
Article CAS PubMed Google Scholar
Roux D, Merlio JP, Quinton A, Lamouliatte H, Balabaud C, Bioulac-Sage P (1987) Agnogenic myeloid metaplasia, portal hypertension and sinusoidal abnormalities. Gastroenterology 92:1067–1072
Article CAS PubMed Google Scholar
Wanless IR, Peterson P, Das A, Boitnott JK, Moore GW, Bernier V (1990) Hepatic vascular disease and portal hypertension in polycythaemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined in autopsy. Hepatology 12:1166–1174
Article CAS PubMed Google Scholar
Mayer J, Schiano TD, Fiel MI, Hoffman R, Mascarenhas JO (2014) An association of myeloproliferative neoplasms and obliterative portal veinopathy. Dig Dis Sci 59:1638–1641
Valla DC, Cazals-Hatem D (2018) Vascular liver diseases on the clinical side: definitions and diagnosis, new concepts. Virchows Arch 473:3–13
Marin Oyarzun CP, Heller PG (2019) Platelets as mediators of thromboinflammation in chronic myeloproliferative neoplasms. Front Immunol 10:1373
Article PubMed PubMed Central Google Scholar
Brunt EM, Gouw ASH, Hubscher SG, Tiniakos DG, Bedossa P, Burt AD, Callea F, Clouston AD, Dienes HP, Goodman ZD, Roberts EA, Roskams T, Terracciano L, Torbenson MS, Wanless I (2014) Pathology of the liver sinusoids. Histopathology 64:907–920
Liu CL, Prapong W, Natkunam Y, Alizadeh A, Montgomery K, Gilks CB, van de Rijn M (2002) Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 161:1557–1565
Article CAS PubMed PubMed Central Google Scholar
Eisen MB, Spellman PT, Brown PO, Botstein. (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863–14868
Article CAS PubMed PubMed Central Google Scholar
Büttner-Herold M, Sticht C, Wiech T, Porubsky S (2021) Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms. Histopathology 78:738–748
Lagana SM, Kudose S, Iuga AC, Lee MJ, Fazlollahi L, Remotti HE, El Portillo A, De Michele S, Koehne de Gonzalez A, Saqi A, Khairallah P, Chong AM, Park H, Uhlemann A-C, Lefkowitch J, Verna EC (2020) Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data. Mod Pathol 33:2147–2155
Article CAS PubMed PubMed Central Google Scholar
Zhao CL, Rapkiewicz A, Maghsoodi-Deerwester M, Gupta M, Cao W, Palaia T, Zhou J, Ram B, Vo D, Rafiee B, Hossein-Zadeh Z, Dabiri B, Hanna I (2021) Pathological findings in the post-mortem liver of patients with coronavirus disease 2019 (COVID-19). Hum Pathol 109:59–68
Article CAS PubMed Google Scholar
Scheuer PJ, The liver and haematological disorders, (1980). In: Scheuer PJ (ed) Liver biopsy interpretation, 3rd edn. Bailliere Tindall, London, pp 221–223
Pieri G, Theocharidou E, Burroughs AK (2013) Liver in haematological disorders. Best Pract Res Clin Gastroenterol 27:513–530
Article CAS PubMed Google Scholar
Tan HK, Leow WQ, Chang PE (2019) Ruxolitinib for the treatment of portal hypertension in a patient with primary myelofibrosis. Gastroenterology. https://doi.org/10.1053/j.gatro.2016.08.059
Article PubMed PubMed Central Google Scholar
Hobbs CM, Manning H, Bennett C, Vasquez L, Severin S, Brain L, Mazharian A, Guerrero JA, Li J, Soranzo N, Green AR, Watson SP, Ghevaert C (2013) JAK V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia. Blood 122:3787–3797
Article CAS PubMed PubMed Central Google Scholar
Etheridge SL, Roh ME, Cosgrove ME, Sangkhae V, Fox NE, Chen J, López JA, Kaushansky K, Hitchcock IS (2014) JAK V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms. Proc Natl Acad Sci USA 111:2295–2300
Article CAS PubMed PubMed Central Google Scholar
Bekendam RH, Ravid K (2023) Mechanisms of platelet activation in cancer-associated thrombosis: a focus on myeloproliferative neoplasms. Front Cell Dev Biol 11:1207395
Article PubMed PubMed Central Google Scholar
Tripodi A, Anstee QM, Sogaard KK, Primignani M, Valla D (2011) Hypercoagulability in cirrhosis: causes and consequences. J Thromb Haemost 9:1713–1723
Article CAS PubMed Google Scholar
Yan M, Geyer H, Mesa R, Attalah E, Callum J, Bartosko J, Yee K, Maganti M, Wong F, Gupta V (2015) Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension. Clin Lymphoma Myeloma Leuk 15:e1–e5
Abu-Hilal M, Tawaker J (2009) Portal hypertension secondary to myelofibrosis with myeloid metaplasia: a study of 13 cases. World J Gastroenterology 15:3128–3133
Dubois A, Dauzat M, Pignodel C, Pomier-Layrargues G, Marty-Double C, Lopez FM, Janbon C (1993) Portal hypertension in lymphoproliferative and myeloproliferative disorders hemodynamic and histological correlations. Hepatology 17:246–250
Article CAS PubMed Google Scholar
Chauhan A, Adams DH, Watson SP, Lalor PF (2016) Platelets: no longer bystanders in liver disease. Hepatology 64:1774–1784
留言 (0)